‘Beyond CBD’: Emerald Health Bioceuticals’ CEO Regarding The Company’s Endocannabinoid Health Items Line

‘Beyond CBD’: Emerald Health Bioceuticals’ CEO Regarding The Company’s Endocannabinoid Health Items Line Emerald Bioscience Inc EMBI 1.6%, an ongoing business that’s the main Emerald Wellness Sciences profile, has a lot more than doubled in value because the start of 12 months. Interested in learning more about Emerald Health’s portfolio of businesses, Benzinga chatted with…